Azra AI appoints Isaac Ullatil and Michele Chulick to its Board of Directors

– USA, TN –  Azra AI, a healthtech leader harnessing AI and workflow automation to accelerate the identification and treatment of cancer, announced the addition of Isaac Ullatil and Michele Chulick to its Board of Directors, bringing a wealth of experience and strategic vision to the company’s leadership.

About Isaac Ullatil

Isaac Ullatil is an accomplished executive with extensive experience in healthcare technology and strategic business development. As the co-founder and former CEO of Hallmark Health Care Solutions (HHCS), Isaac has led initiatives that saved clients hundreds of millions of dollars in labor and operational costs. Recognized as one of the Top 50 Healthcare Technology CEOs in 2022, he has a strong track record of developing high-end technology solutions and reengineering business processes to optimize operations. Isaac’s strategic insights and leadership will guide Azra AI in navigating the complexities of the healthcare landscape and achieving sustained growth.

About Michele Chulick

Michele Chulick brings over 30 years of leadership experience in the healthcare sector, including her tenure as President and CEO of Wyoming Medical Center (WMC). Under her leadership, WMC expanded its telehealth network and completed a significant affiliation with Banner Health, enhancing the hospital’s capabilities and financial foundation. Michele’s expertise in strategic planning, value-based care management, and healthcare operations will be instrumental in shaping Azra AI’s strategic direction and ensuring alignment with customer needs.

About Azra AI

Azra AI is a healthtech firm that leverages advanced AI and machine learning to automate oncology workflows. Its proven SaaS enterprise platform is used by more than 200 hospitals and cancer centers across the country to identify positive cancer diagnoses and incidental findings in real-time, classify by primary site, and route those patients to cancer navigators and other staff to immediately start the cancer care journey. The results include faster time to treatment, increased navigator time with patients, and better oncology patient retention. Additionally, the solution delivers dramatic operational and financial gains through intelligent automation.

For more information: https://www.azra-ai.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.